Finance

Beta
Ask
Lists
688639:SHA
Anhui Huaheng Biotechnology Co Ltd
CN¥21.47
+1.27%
(+0.27) 1D
Jun 15, 10:50:23 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688639...
Open
CN¥21.30
High
CN¥21.68
Low
CN¥21.07
Mkt. cap
5.30B
Avg. vol.
5.15M
Volume
2.61M
Dividend
0.75%
Quarterly dividend
CN¥0.04
Ex-dividend date
May 12, 2026
P/E ratio
43.02
52-wk high
CN¥43.60
52-wk low
CN¥19.99
EPS
CN¥0.50
No. of employees
2K
Open
CN¥21.30
High
CN¥21.68
Low
CN¥21.07
Mkt. cap
5.30B
Avg. vol.
5.15M
Volume
2.61M
Dividend
0.75%
Quarterly dividend
CN¥0.04
Ex-dividend date
May 12, 2026
P/E ratio
43.02
52-wk high
CN¥43.60
52-wk low
CN¥19.99
EPS
CN¥0.50
No. of employees
2K
News stories
From sources across the web
About Anhui Huaheng Biotechnology Co Ltd
CEO-
Employees2.25K
FoundedApr 13, 2005
Headquarters-
SectorCommodity chemical
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
802.10M
704.38M
668.30M
771.26M
Cost of goods sold
619.43M
537.48M
593.26M
609.59M
Cost of revenue
619.43M
537.48M
593.26M
609.59M
Research and development expenses
34.80M
38.25M
44.28M
35.01M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
68.18M
58.97M
79.00M
68.10M
Operating expense
104.77M
92.48M
130.84M
102.70M
Total operating expenses
724.20M
629.96M
724.10M
712.28M
Operating income
77.90M
74.42M
-55.80M
58.98M
Other non operating income
-4.54M
-3.05M
592.32K
-10.15M
EBT including unusual items
63.89M
52.76M
-45.77M
35.90M
EBT excluding unusual items
67.47M
58.80M
-68.94M
36.95M
Income tax expense
3.88M
2.48M
-10.21M
-1.62M
Effective tax rate
6.07%
4.71%
22.30%
-4.52%
Other operating expenses
758.47K
-1.27M
8.74M
-318.36K
Net income
63.80M
52.73M
-35.21M
42.10M
Net profit margin
7.95%
7.49%
-5.27%
5.46%
Earnings per share
-
-
-
-
Interest and investment income
-
10.88M
-
703.99K
Interest expense
-8.87M
-20.47M
-10.80M
-12.58M
Net interest expenses
-8.87M
-9.59M
-10.80M
-11.87M
Depreciation and amortization charges
-
-
-
-
EBITDA
124.73M
109.09M
-2.10M
112.68M
Gain or loss from assets sale
60.89K
-60.89K
-122.57K
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more